Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · IEX Real-Time Price · USD
32.23
+0.51 (1.61%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Revolution Medicines Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017
Cash & Equivalents
699.18163.15110.23105.3516.8769.89.08
Short-Term Investments
1,157483.53468.56336.47106.100
Cash & Cash Equivalents
1,856646.68578.79441.83122.9769.89.08
Cash Growth
187.00%11.73%31.00%259.29%76.18%668.81%-
Receivables
1.254.675.936.398.747.30
Other Current Assets
22.048.835.055.92.278.330.36
Total Current Assets
1,879660.19589.77454.12133.9885.439.44
Property, Plant & Equipment
100.0173.7471.2436.347.156.875.25
Goodwill and Intangibles
72.3573.4274.4875.5576.6277.690
Other Long-Term Assets
10.064.592.51.392.780.590.38
Total Long-Term Assets
182.42151.75148.22113.2886.5585.165.64
Total Assets
2,062811.93737.99567.4220.53170.5915.08
Accounts Payable
61.7921.3114.0612.6111.45.243.35
Deferred Revenue
04.4618.9320.5931.8545.240
Current Debt
7.376.776.213.67000
Other Current Liabilities
74.6929.4521.1510.3-0.2-19.934.25
Total Current Liabilities
143.8561.9860.3547.1843.0530.557.6
Long-Term Debt
80.5857.4360.4228.99000
Other Long-Term Liabilities
11.097.3314.6516.5624.9443.382.95
Total Long-Term Liabilities
91.6664.7675.0745.5524.9443.382.95
Total Liabilities
235.51126.74135.4292.7367.9973.9310.55
Total Debt
87.9464.2166.6332.66000
Debt Growth
36.97%-3.64%104.00%----
Retained Earnings
-1,137.71-701.34-452.64-265.55-157.39-109.72-67.93
Comprehensive Income
0.54-1.78-0.380.120.0700
Shareholders' Equity
1,826685.19602.57474.68-152.57-108.42-67.72
Net Cash / Debt
1,768582.48512.16409.16122.9769.89.08
Net Cash / Debt Growth
203.54%13.73%25.17%232.73%76.18%668.81%-
Net Cash Per Share
15.637.227.037.4644.3530.365.27
Working Capital
1,735598.2529.42406.9590.9354.881.84
Book Value Per Share
16.148.508.288.65-55.03-47.16-39.29
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).